CCND1 and neoplasm: It was reported that cyclin D1 overexpression is associated with poor prognosis in OSCC, encompassing lymph node involvement, greater tumor size, progressive clinical stage, lower disease-free and overall survival, and lack of therapeutic responsiveness (Ramos-García et al. 2019).